Clinical Trial Update: High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update on high-dose chemotherapy in oligo-metastatic homologous recombination deficient breast cancer; study status ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING